Microsoft word - 1597 tmk mock-up.doc

Spring can come early for allergy sufferers. In many parts of the U.S., trees begin releasing pollen, one of the most common allergy triggers, in February and continue through May. In southern states, pollen season can begin as early as January. If pollen and other allergens cause sneezing, runny nose, and itchy, watery eyes for you or a family member, there are things you can do to The first step is to avoid or reduce your exposure to pollen and other substances that trigger your symptoms. If that’s not enough, you should talk to your doctor about trying an antihistamine medicine, such as ZYRTEC® (cetirizine HCl), to relieve sneezing, runny nose, and itchy, watery eyes. If your allergy symptoms are limited to your eyes, allergy eye drops may be an alternate solution. • ZYRTEC® 10mg provides the fastest 24-hour relief of upper-respiratory allergy symptoms* (Day, 1998 and Day, 2001).1 ZYRTEC®
is available over-the-counter (OTC) at original prescription strength. • VISINE®-A® provides more powerful relief of red allergy eyes than the leading prescription allergy eye drops. VISINE®-A®
combines an antihistamine with a redness reliever for the relief of itchy, red eyes that starts working in minutes. Before taking any medicine, be sure to read and follow the label carefully. If you have questions, ask your pharmacist or health care professional. Before changing or discontinuing use of any prescription medicine, talk to your health care provider. If you have a flexible spending account (or health savings account), these OTC medicines may be eligible expenses. Talk to your health The enclosed information sheet offers some additional facts about ZYRTEC® and VISINE®-A® products, as well as coupons for ZYRTEC® and VISINE®-A® products. You can also visit for more helpful information about living with allergies, choosing
appropriate medicines, and managing your health care dollars.
NextRx OTC Instant Discount!

ZYRTEC® is available through NextRx OTC, a department of NextRx, our pharmacy benefit management company. For details and pricing, see the attached order form, or go online to, or call us at 877-373-6759 x-2 (8 a.m. - 7 p.m., CT, Mon-Fri). *Among name brand OTC products. Use only as directed. ZYRTEC® is a trademark of UCB Pharma, used under license. VISINE®-A® is a registered trademark of Johnson and Johnson Healthcare Products, a Divison of McNEIL-PPC, Inc. 1 Day, J.H., Briscoe, M., Widlitz, M.D. (May 1998), Cetirizine, loratadine, or placebo in subjects with seasonsal allergic rhinitis: Effects after controlled ragweed pollen challenge in an environmental exposure unit. Journal of Allergy & Clinical Immunology, Vol. 101, Number 5, 638-645. Day, J.H., Briscoe, M., Rafeiro, E., Chapman, D., Kramer, B. (Dec. 2001), Comparative onset of action and symptom relief with cetirizine, loratadine, or placebo in an environmental exposure unit in subjects with seasonal allergic rhinitis: confirmation of a test system, Annals of Allergy, Asthma, & Immunology, Vol. 97, 474-481.
This mailing was funded by McNeil Consumer Healthcare, a Division of McNEIL-PPC, Inc., which is the maker of ZYRTEC®. No patient information
has been provided to McNeil.

The information contained herein is provided for educational purposes only and shall not constitute medical advice. Please consult your physician for specific treatment options and recommendations best suited for your individual
circumstances and before beginning any lifestyle program. WellPoint NextRx and McNeil do not endorse or take responsibility for the other's printed materials or products. If you do not wish to participate in or receive future mailings
regarding this program, please contact us at 866-614-0147.

Si necesita ayuda en español para entender este documento, puede solicitarla sin costo adicional, llamando al número de servicio al cliente que aparece al dorso de su tarjeta de identificación o en el folleto de inscripción.
Wel Point NextRx is a division of Wel Point, Inc. and is also a registered service mark of Wel Point, Inc. Wel Point NextRx services are provided by a Wel Point PBM (either NextRx Services, Inc. or NextRx, LLC, as applicable).


Microsoft word - bcydb3pt.342

UNITED STATES PATENT AND TRADEMARK OFFICE James D. Weinberger, Laura Popp-Rosenberg and Giselle C. Woo of Fross Zelnick Lehrman & Zissu PC for McNeil-PPC, Inc. Mark J. Liss, Caroline L. Stevens and Michelle L. Calkins of Leydig Voit & Mayer Before Zervas, Kuhlke and Mermelstein, Administrative Trademark Judges. Opinion by Kuhlke, Administrative Trademark Judge: Applicant, Walgreen C

Pii: s0010-7824(02)00314-

Attitudes and experiences with levonorgestrel 100 ␮g/ethinyl estradiol20 ␮g among women during a 3-month trialYolanda H. Wimberlya, Sian Cottona, Abbey M. Wanchicka, Paul A. Succopb,a Department of Pediatrics, University of Cincinnati College of Medicine, Cincinnati, OH, USA b Department of Environmental Health, University of Cincinnati College of Medicine, Cincinnati, OH, USA c Departm

Copyright © 2010-2014 Metabolize Drugs Pdf